Cancer Research Institute shared a post on LinkedIn:
“Aiming to improve the understanding of immune cell organization in ovarian cancer, a new study from researchers including CRI-Irvington Postdoctoral Fellow Dr. Ayana Ruffin of Emory University and former CRI-V Foundation CLIP Investigator Dr. Tullia Bruno of University of Pittsburgh sheds light on the development of tertiary lymphoid structures (TLS) in different tumor sites from patients with high-grade serous ovarian cancer.
Explore their findings, and discover how their insights could eventually lead to new treatment approaches for ovarian cancer.”